Les Meilleurs doctors pour le traitement de cancer de l'estomac en Israël - TOP-25 des médecins

Le Dr Pelles Sharon dirige le service des tumeurs de l'appareil digestif au centre médical Sourasky – formé au Royal Marsden Cancer Centre de Londres sous la direction du professeur David Cunningham.

• Se spécialiser dans les cancers de l'œsophage, de l'estomac, du pancréas et du foie
• Être expert en traitements avancés tels que l'HIPEC et l'immunothérapie
• Être directeur de l'Institut des tumeurs de l'appareil digestif
• Être maître de conférences à la faculté de médecine de l'université de Tel Aviv
• Être membre des associations israéliennes d'oncologie et de radiologie

Le professeur Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky, se spécialisant dans les cas complexes de sarcomes.

• Plus de 25 ans d'expérience en oncologie
• Formation spécialisée (Fellowship) à l'Institut Gustave Roussy à Paris
• Professeur associé à la faculté de médecine Sackler
• Membre actif de l'ESMO Sarcoma Faculty
• Auteur de nombreuses publications sur les traitements des sarcomes

Le professeur Arber dirige le centre de prévention du cancer du centre médical Sourasky (Ichilov) – l'un des principaux hôpitaux d'Israël pour les soins oncologiques.

• Avoir plus de 30 ans d'expérience dans le traitement des tumeurs du tractus gastro-intestinal (GI)
• Diriger des études sur la thérapie génique pour les cancers gastro-intestinaux et la détection précoce du cancer
• Effectuer des travaux de recherche au NewYork-Presbyterian Center aux États-Unis
• Auteur de plus de 300 articles scientifiques sur l'oncologie gastro-entérologique
• Membre de sociétés clés, notamment de l'European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le professeur Ido Wolf dirige le département d'oncologie du centre médical Sourasky de Tel Aviv, un centre national de référence pour les cancers digestifs.

• Plus de 15 ans d'expérience en oncologie médicale et en médecine interne
• Se spécialiser dans le traitement systémique des cancers du système digestif
• Être titulaire d'un diplôme de médecine de l'université Ben-Gourion
• Occuper un poste de direction au sein du service d'oncologie d'un grand hôpital

Dirige le département de chirurgie colorectale et est un grand spécialiste de la procédure de Whipple complexe et de la chirurgie abdominale mini-invasive.

• Plus de 20 ans d'expérience en tant que chirurgien viscéral
• Expert en techniques ouvertes et laparoscopiques
• Dirige son service au centre médical Sourasky (Ichilov)

Directeur de l'hospitalisation oncologique au centre médical de Tel Aviv (Ichilov) – un centre de cancérologie national majeur – et chercheur principal dans des essais cliniques.

• Plus de 15 ans de spécialisation en oncologie clinique depuis 2005
• Investigateur principal et participant dans des études oncologiques de phases 1, 2 et 3
• Licence médicale israélienne et formation formelle en oncologie au centre médical de Tel Aviv
• Expertise certifiée en médecine interne et en oncologie

Le Dr Joseph Klauzner est l'un des meilleurs chirurgiens d'Israël pour la procédure de Whipple, une opération clé pour le cancer de l'estomac et du pancréas. Il dirige le département de chirurgie du centre médical Sourasky.

• Avoir plus de 45 ans d'expérience chirurgicale
• Se spécialiser dans les chirurgies gastro-intestinales et pancréatiques
• Être expert en opérations colorectal complexes
• Occuper le poste de président de la chirurgie

Le professeur Zamir Halperin dirige le département du système digestif du centre médical de Tel Aviv avec des décennies d'expertise dans les maladies gastro-intestinales et les troubles hépatiques.

• Directeur de l'Institut de gastro-entérologie pendant 14 ans
• Ancien président de l'Association israélienne de gastro-entérologie
• Formé à la Cleveland Clinic Foundation et au Royal Free Hospital
• Professeur à la Sackler School of Medicine, Université de Tel Aviv
• Se spécialiser en endoscopie avancée et en maladies inflammatoires de l'intestin

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Le Dr Kariv est spécialisé en chirurgie laparoscopique et colorectale, apportant précision et expertise au traitement du cancer de l'estomac.

• Se concentrer sur les techniques mini-invasives pour de meilleurs résultats pour les patients
• Se spécialiser en chirurgie colorectale, assurant des soins complets
• Pratiquer au centre médical Assuta, reconnu pour ses traitements oncologiques de pointe